Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
18.15
+0.15 (0.83%)
At close: Jun 26, 2026, 4:00 PM EDT
18.14
-0.01 (-0.06%)
Pre-market: Jun 29, 2026, 7:03 AM EDT
Trevi Therapeutics Market Cap
Trevi Therapeutics has a market cap or net worth of $2.58 billion as of June 29, 2026. Its market cap has increased by 246.06% in one year.
Market Cap
2.58B
Enterprise Value
2.41B
1-Year Change
246.06%
Ranking
Category
Stock Price
$18.15
Market Cap Chart
Since May 7, 2019, Trevi Therapeutics's market cap has increased from $84.99M to $2.58B, an increase of 2,932.07%. That is a compound annual growth rate of 61.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 2.58B | 60.51% |
| Dec 31, 2025 | 1.61B | 336.04% |
| Dec 31, 2024 | 368.19M | 330.28% |
| Dec 29, 2023 | 85.57M | -26.01% |
| Dec 30, 2022 | 115.65M | 472.04% |
| Dec 31, 2021 | 20.22M | -54.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Disc Medicine | 2.86B |
| Celldex Therapeutics | 2.77B |
| Tarsus Pharmaceuticals | 2.71B |
| Kailera Therapeutics | 2.70B |
| MBX Biosciences | 2.49B |
| Biohaven | 2.38B |
| Pharvaris | 2.38B |
| Nurix Therapeutics | 2.37B |